BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 12566391)

  • 1. Loss of CBP acetyltransferase activity by PHD finger mutations in Rubinstein-Taybi syndrome.
    Kalkhoven E; Roelfsema JH; Teunissen H; den Boer A; Ariyurek Y; Zantema A; Breuning MH; Hennekam RC; Peters DJ
    Hum Mol Genet; 2003 Feb; 12(4):441-50. PubMed ID: 12566391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defect of histone acetyltransferase activity of the nuclear transcriptional coactivator CBP in Rubinstein-Taybi syndrome.
    Murata T; Kurokawa R; Krones A; Tatsumi K; Ishii M; Taki T; Masuno M; Ohashi H; Yanagisawa M; Rosenfeld MG; Glass CK; Hayashi Y
    Hum Mol Genet; 2001 May; 10(10):1071-6. PubMed ID: 11331617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The PHD type zinc finger is an integral part of the CBP acetyltransferase domain.
    Kalkhoven E; Teunissen H; Houweling A; Verrijzer CP; Zantema A
    Mol Cell Biol; 2002 Apr; 22(7):1961-70. PubMed ID: 11884585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP.
    Petrij F; Giles RH; Dauwerse HG; Saris JJ; Hennekam RC; Masuno M; Tommerup N; van Ommen GJ; Goodman RH; Peters DJ
    Nature; 1995 Jul; 376(6538):348-51. PubMed ID: 7630403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of CBP (CREBBP) gene deletions in Rubinstein-Taybi syndrome patients using real-time quantitative PCR.
    Coupry I; Monnet L; Attia AA; Taine L; Lacombe D; Arveiler B
    Hum Mutat; 2004 Mar; 23(3):278-84. PubMed ID: 14974086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic analysis of the Rubinstein-Taybi syndrome: five cosmids should be used for microdeletion detection and low number of protein truncating mutations.
    Petrij F; Dauwerse HG; Blough RI; Giles RH; van der Smagt JJ; Wallerstein R; Maaswinkel-Mooy PD; van Karnebeek CD; van Ommen GJ; van Haeringen A; Rubinstein JH; Saal HM; Hennekam RC; Peters DJ; Breuning MH
    J Med Genet; 2000 Mar; 37(3):168-76. PubMed ID: 10699051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rubinstein-Taybi Syndrome and Epigenetic Alterations.
    Korzus E
    Adv Exp Med Biol; 2017; 978():39-62. PubMed ID: 28523540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CREBBP mutations in individuals without Rubinstein-Taybi syndrome phenotype.
    Menke LA; van Belzen MJ; Alders M; Cristofoli F; ; Ehmke N; Fergelot P; Foster A; Gerkes EH; Hoffer MJ; Horn D; Kant SG; Lacombe D; Leon E; Maas SM; Melis D; Muto V; Park SM; Peeters H; Peters DJ; Pfundt R; van Ravenswaaij-Arts CM; Tartaglia M; Hennekam RC
    Am J Med Genet A; 2016 Oct; 170(10):2681-93. PubMed ID: 27311832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rubinstein-Taybi syndrome: molecular findings and therapeutic approaches to improve cognitive dysfunction.
    Hallam TM; Bourtchouladze R
    Cell Mol Life Sci; 2006 Aug; 63(15):1725-35. PubMed ID: 16786226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Administration of BMP2/7 in utero partially reverses Rubinstein-Taybi syndrome-like skeletal defects induced by Pdk1 or Cbp mutations in mice.
    Shim JH; Greenblatt MB; Singh A; Brady N; Hu D; Drapp R; Ogawa W; Kasuga M; Noda T; Yang SH; Lee SK; Rebel VI; Glimcher LH
    J Clin Invest; 2012 Jan; 122(1):91-106. PubMed ID: 22133875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation of the CH1 Domain in the Histone Acetyltransferase CREBBP Results in Autism-Relevant Behaviors in Mice.
    Zheng F; Kasper LH; Bedford DC; Lerach S; Teubner BJ; Brindle PK
    PLoS One; 2016; 11(1):e0146366. PubMed ID: 26730956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic mechanisms of Rubinstein-Taybi syndrome.
    Park E; Kim Y; Ryu H; Kowall NW; Lee J; Ryu H
    Neuromolecular Med; 2014 Mar; 16(1):16-24. PubMed ID: 24381114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiplex ligation-dependent probe amplification detection of an unknown large deletion of the CREB-binding protein gene in a patient with Rubinstein-Taybi syndrome.
    Calì F; Failla P; Chiavetta V; Ragalmuto A; Ruggeri G; Schinocca P; Schepis C; Romano V; Romano C
    Genet Mol Res; 2013 Jan; 12(3):2809-15. PubMed ID: 23315884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variation in microdeletions of the cyclic AMP-responsive element-binding protein gene at chromosome band 16p13.3 in the Rubinstein-Taybi syndrome.
    Blough RI; Petrij F; Dauwerse JG; Milatovich-Cherry A; Weiss L; Saal HM; Rubinstein JH
    Am J Med Genet; 2000 Jan; 90(1):29-34. PubMed ID: 10602114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rubinstein-Taybi syndrome caused by a De Novo reciprocal translocation t(2;16)(q36.3;p13.3).
    Petrij F; Dorsman JC; Dauwerse HG; Giles RH; Peeters T; Hennekam RC; Breuning MH; Peters DJ
    Am J Med Genet; 2000 May; 92(1):47-52. PubMed ID: 10797422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Truncated CBP protein leads to classical Rubinstein-Taybi syndrome phenotypes in mice: implications for a dominant-negative mechanism.
    Oike Y; Hata A; Mamiya T; Kaname T; Noda Y; Suzuki M; Yasue H; Nabeshima T; Araki K; Yamamura K
    Hum Mol Genet; 1999 Mar; 8(3):387-96. PubMed ID: 9949198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional analysis of the p300 acetyltransferase domain: the PHD finger of p300 but not of CBP is dispensable for enzymatic activity.
    Bordoli L; Hüsser S; Lüthi U; Netsch M; Osmani H; Eckner R
    Nucleic Acids Res; 2001 Nov; 29(21):4462-71. PubMed ID: 11691934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rubinstein-Taybi Syndrome: spectrum of CREBBP mutations in Italian patients.
    Bentivegna A; Milani D; Gervasini C; Castronovo P; Mottadelli F; Manzini S; Colapietro P; Giordano L; Atzeri F; Divizia MT; Uzielli ML; Neri G; Bedeschi MF; Faravelli F; Selicorni A; Larizza L
    BMC Med Genet; 2006 Oct; 7():77. PubMed ID: 17052327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotype-phenotype correlations in Rubinstein-Taybi syndrome.
    Schorry EK; Keddache M; Lanphear N; Rubinstein JH; Srodulski S; Fletcher D; Blough-Pfau RI; Grabowski GA
    Am J Med Genet A; 2008 Oct; 146A(19):2512-9. PubMed ID: 18792986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spectrum of CREBBP mutations in Indian patients with Rubinstein-Taybi syndrome.
    Sharma N; Mali AM; Bapat SA
    J Biosci; 2010 Jun; 35(2):187-202. PubMed ID: 20689175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.